Omics Sequencing of Specimen Derived From Mother-Infant-Pairs

Zhujiang Hospital100 enrolled

Overview

The investigators aim to collect breast-milk and feces from the participants, and apply culture techniques as well as omics sequencing technology to probe into the microbial and metabolomic signature of the specimens.

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Healthy Breast-milk Collection Feces

Interventions

Sample collectionOTHER

Collect breast-milk and feces from mother-infant-pairs.

Eligibility

Sex: ALLMax age: 40 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * healthy pregnant women aged between 20y and 40y. * Vaginal birth * BMI\<23.5 before pregnancy * Infants' birth weight, between 2500g and 4000g. Exclusion Criteria: * gestational diabetes * diagnosis of depressive disorder during pregnancy * gestational hypertension * diagnosis of other diseases during pregnancy * Under probiotics or antibiotic treatment from 3 months prior to pregnancy till 3 months after delivery * histrory of smoking and drinking alcohol * history of diarrhea from 3 months prior to pregnancy till 3 months after delivery

Locations (1)

Zhujiang Hospital

Guangzhou, Guangdong, China

RECRUITING

Outcomes

Primary Outcomes

Compare the omics differences of the specimens between the experimental and control groups

Apply 16S amplicon sequencing and shotgun sequencing technology to obtain microbial structure of the specimens. The differences of microbial structure will be compared between the experimental and control groups. Significance among multiple groups was tested using a one-way analysis of variance (ANOVA), followed by the least significant difference (LSD) post hoc test. Groups with different characters denoting a significant difference, while having the same character denotes p-value \> 0.05 in LSD test.

Time frame: 2021.7.1-2026.12.30

Compare the microbial feature differences of the specimens between the experimental and control groups

Apply traditional culture technologies to validate and obtain human source bacteria.The differences of frequencies of probiotics will be compared between the experimental and control groups. Depending on the distribution of the variables, either the Mann-Whitney test or the unpaired Student's t-test was employed for quantitative variables. The Kruskal-Wallis test for mean values was used to evaluate non-parametric comparisons between participants in all groups. Significance among multiple groups was tested using a one-way analysis of variance (ANOVA), followed by the least significant difference (LSD) post hoc test. Groups with different characters denoting a significant difference, while having the same character denotes p-value \> 0.05 in LSD test.

Time frame: 2021.7.1-2026.12.30

Secondary Outcomes

Compare the health status differences between the experimental and control groups

After a brief introduction to the survey, participants were asked to complete a questionnaire. The differences of health status will be compared between the experimental and control groups. Depending on the distribution of the variables, either the Mann-Whitney test or the unpaired Student's t-test was employed for quantitative variables. The Kruskal-Wallis test for mean values was used to evaluate non-parametric comparisons between participants in all groups.

Time frame: 2021.7.1-2026.12.30

Central Contacts

Ying Ma, Doctor

CONTACT

13113361169 mayingwuzhuoyi@126.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.